FIXX - Homology Medicines GAAP EPS of -$0.59 misses by $0.11 revenue of $0.80M misses by $0.16M
- Homology Medicines press release ( NASDAQ: FIXX ): Q3 GAAP EPS of -$0.59 misses by $0.11 .
- Revenue of $0.80M (-52.1% Y/Y) misses by $0.16M .
- As of September 30, 2022, Homology had approximately $201.1 million in cash, cash equivalents
For further details see:
Homology Medicines GAAP EPS of -$0.59 misses by $0.11, revenue of $0.80M misses by $0.16M